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Background: The WASP (Wiskott-Aldrich syndrome protein) and WAVE (WASP Verpolin homologous) family of
proteins are structurally related and responsible for regulation of actin polymerization through their interaction with
actin related proteins 2&3 (ARP 2/3). WAVE-3 has exhibited an association with disease progression and poorer
prognosis of certain malignancies. In the current study, we determined the role of WAVE-3 in hepatocyte growth
factor induced cellular changes including cell matrix interaction, invasion and cellular motility, and pathways that
may be responsible for the changes in prostate cancer cells.
Methods: We used hammer head ribozymes to knock down the expression of WAVE-3 in PC-3 prostate cancer cell
line. In vitro cellular functional assays including growth, invasion, adhesion, motility and invasion, were performed
to assess the effects of WAVE-3 knock down. Further experimentation was performed to investigate the role of
different pathway through expression and phosphorylation status of various intermediate proteins.
Results: WAVE-3 knockdown reduced invasive potential and motility of prostate cancer cells. Following addition of
HGF, control cells showed significantly increased invasion and motility (p value <0.5) and marked increase in cellular
growth. However, WAVE-3 knockdown cell line failed to show any increase in these trends (p value <0.5) except
increased growth compared with control cells. Further experiments revealed that HGF-induced activation of Paxillin
was weakened by the knockdown of WAVE-3. Our study also indicated that reduced invasiveness following WAVE-3
knockdown, may be related to reduce activity of MMP-2.
Conclusions: Our studies suggest a vital role of WAVE-3 in HGF induced invasion and migration in which Paxillin
and MMP-2 are involved. Further study will shed light on its potential as therapeutic target to suppress local
invasion and metastasis of prostate cancer cells.
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Prostate cancer is the most commonly diagnosed male
malignancy in the US and UK [1, 2]. Morbidity and mor-
tality is mainly related to metastatic disease [3]. Under-
standing the mechanism and molecules involved in
creation of metastatic disease will help in devising the
treatments and metastatic prevention strategies.
Invasive and metastatic potential of any cancer is
dependent upon expression of different cellular charac-
teristics at various steps of the metastatic cascade.
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polymerization. Cells exhibit these changes in response
to interaction with the external environment through
surface proteins. Integrins is one such class of proteins
responsible for regulating the binding of a cell to com-
ponents of the external environment. Paxillin, through
tightly regulated interactions with multiple structural
and signaling molecules, serves as a nexus for the con-
trol of the Rho family of GTPases which act as essential
regulators of the actin polymerization [4, 5]. Paxillin
contributes to the regulation of the Rho family of
GTPases by indirectly recruiting various GEFs (guanine-
nucleotide–exchange factors), and GAPs (GTPase acti-
vating proteins) which promote the hydrolysis of GTP
to GDP [6]. It has been observed that an increase ins article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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ability of the cell [7]. Phosphorylation of Paxillin in
metastatic cells is influenced by numerous growth fac-
tors [8].
Hepatocyte growth factor (HGF) utilises one such
pathway to mediate cell-matrix adhesion and has been
shown to enhance paxillin phosphorylation [9]. HGF
derived from prostate stroma, promotes proliferation,
differentiation, motility, and invasion of malignant epi-
thelial cells indicating possible involvement in the pro-
gression of prostate cancer [10]. The serum levels of
HGF and PSA are found to be significantly increased in
prostate cancer patients [11]. Higher plasma levels of
HGF in men with hormone-refractory prostate cancer
are associated with a decreased patient survival [12].
The WASP (Wiskott-Aldrich syndrome protein) and
WAVE (WASP Verpolin homologous) family of pro-
teins are structurally related and responsible for regula-
tion of actin polymerization through their interaction
with actin related proteins 2&3 (ARP 2/3) [13]. WASP
family includes WASP and N-WASP. WAVE family
comprise of WAVE-1, 2 and 3. WASP and WAVE family
act as downstream regulators of small GTPase like Rho
and Rac responsible for signal transduction generated
by different regulatory factors. Rac (GTPase) controls
the formation of lamellipodia through regulation of
WAVE family. WAVE-1 appears to be crucial for dorsal
ruffles, while WAVE-2 is necessary for formation of la-
mellipodia. WAVE-3 was found to be an aetiological
factor in the development of low grade neuroblastoma
[14]. Prior studies have shown that elimination of
WAVE-3 from breast and prostate cancer cells reduces
their invasive potential through reduction in motility
and reduced expression of enzymes responsible for
extra cellular matrix degradation [15-17].
HGF can increase both invasion and haptotactic migra-
tion of prostate cancer cells [18]. Previous studies have
clearly demonstrated the loss of aggressive phenotype in
different cancer cells following elimination of WAVE-3,
including prostate cancer cells [16, 19]. This study exam-
ined the effect of WAVE-3 on the HGF induced migration
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Materials
PC-3 cells (European Collection of Cell Cultures, Salisbury,
United Kingdom) were maintained in Dulbecco’s modified
Eagle’s (DMEM)-F12 medium supplemented with 10 %
fetal calf serum and antibiotics. Anti-WAVE3 antibody was
obtained from Santa Cruz Biotechnology, Santa Cruz, CA.
Mouse monoclonal anti-Paxillin antibody was purchased
from BD Bioscience. Other kits and reagents were obtained
from Sigma-Aldrich, Poole, UK. The recombinant human
HGF/SF was from HGF/SF cDNA transfected Chinese ham-
ster ovary cell and was a kind gift from Dr. T. Nakamura,
Osaka, Japan.
Construction of anti-WAVE3 ribozyme transgenes,
and transfection
Anti-WAVE-3 ribozyme transgenes were synthesised
and then cloned into pEF6/V5-His-TOPO-TA plasmid
vector (Invitrogen, Paisley, UK). The anti-WAVE3 trans-
genes were then used to transfect PC-3 cells following a
previously described procedure [19].
RNA isolation and PCR
RNA was isolated from selected cells using total RNA iso-
lation reagent (ABgene, Surrey, UK). Following quantifica-
tion, this RNA was used to construct complimentary
DNA using DuraScript reverse transcriptase-polymerase
chain reaction (RT-PCR) kit (Invitrogen, Paisley, UK). This
DNA was used for routine PCR and Q-PCR to confirm
the knock down of WAVE-3 and expression of different
genes. Details of primers are provided in Table 1.
Western blot
Equal amount of proteins were separated from cell lysate
using DC Protein Assay kit (Bio-Rad Laboratories, Hemmel
Hempstead, UK) and an ELx800 spectrophotometer (Bio-
Tek, Wolf Laboratories, York, UK). These proteins were
separated using Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and blotted on to nitrocellu-
lose membrane. Membrane was treated with milk to block
non-specific proteins prior to probing with anti-WAVE-3








Fig. 1 Knockdown of WAVE-3 in PC-3 cells using anti-WAVE3 ribozyme
transgenes. a. RT-PCR shows the WAVE-3 transcript. b. Western blot
reveals the WAVE-3 protein. Total RNA and protein were extracted from
the cells within the first two weeks after the selection. The cells were
maintained medium with 0.5 μg/ml blasticidin. Three independent
experiments were carried out for a confirmation of the knockdown
using the anti-WAVE-3 ribozyme transgenes
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analysed using Supersignal West Dura system and docu-
mented using a gel documentation system (UVITech,
Cambridge, United Kingdom).
Immunoprecipitation for detection of paxillin
phosphorylation
The cells were cultured in serum free medium for one hour,
followed by treatment with HGF containing serum free
medium for 30 min. Following this, the cells were harvested
and lysed. Tyrosine phosphorylated proteins were immuno-
precipitated using PY20 antibody (1:500 dilution) and pro-
tein A/G agarose beads (Santa Cruz Biotechnology, Calne,
UK). Immunoprecipitates were then separated by SDS-
PAGE (10 % gel), electroblotted on to nitrocellulose mem-
brane and probe with specific antibodies.
Zymography
Gelatinase zymography was performed in 8 % SDS Poly-
acrylamide Gel in the presence of 0.1 % gelatin under
non-reducing conditions [20]. Upon renaturation of the
enzyme, the gelatinases digest the gelatin in the gel and
give clear bands against an intensely stained background.
Gels were subsequently scanned on digital scanner and
digital images were saved for subsequent analysis.
Cell growth assay
Cell growth was assessed using previously described
method [21]. In this method, 3000 cells are added each well
in 96 well plates and growth was assessed after 72 and
120 h, in the presence or absence of HGF (40 ng/ml) con-
taining medium. Crystal violet was used to stain the cells,
which was extracted and subsequently used to quantify
through absorbance of light (wave length 540 nm) using an
ELx800 spectrophotometer. Amounts of absorbance repre-
sented the number of cell and change was calculated by
percentage increase as compared to baseline reading.
Cell matrix adhesion assay
Cells were added to a Matrigel precoated (5 μg/well) 96-
well plate (30,000/well). Cells were incubated for 40 min
with or without HGF/SF (40 ng/ml). Non-adherent cells
were washed with BSS buffer. Adherent cell were stained
with crystal violet (200 μL/well) and then documented.
Invasion assay
Transwell inserts with pore size of 8 μm were precoated
with Matrigel (50 μg/well, BD Biosciences, Oxford UK)
and used for invasion assay as previously described [22].
Cells were added along with medium (20,000 cells/insert).
Experiment was run in duplicate for each cell line with or
without HGF/SF (40 ng/ml). After 72 h of incubation, the
number of cells that have invaded through the basementmembrane were counted following staining with crystal
violet solution as described above in adhesion assay.Migration assay
PC-3 cells were seeded into a 24-well plate (250,000 cells/
well) and allowed to form a monolyer by an overnight cul-
ture. The cell monolayer was scraped using a sharpened
200 μl plastic tip. Closure of the wounds was photo-
graphed. Migration of the cells was measured using Ima-
geJ software (National Institutes of Health, USA).Cell motility assay using cytodex-2 beads
Cell motility was assessed by dissociation from cytodex-
2 μ carrier beads following with or without treatment by
HGF/SF (40 ng/ml) and was adapted from previous pub-
lished methods [23]. Cells at a density of 1 × 106 cells/ml
were cultured in 10 ml of DMEM medium containing
250 μg/ml of beads for 24 h at 37 °C. The cell/bead
complex was seeded into a 24 well plate in triplicate,
and cultured with (HGF 40 ng/ml) or without HGF for
4 h at 37 °C. Migrated cells were counted following the
fixation and staining with crystal violet.
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Following the treatment to the cells, immunofluorescent
staining was performed using primary antibody and sec-
ondary antibody (labelled with FITC). Cells were viewed
under fluorescent microscope (Olympus) and photos were
taken.Data analysis
Mann Whitney test was initially used to check the nor-
mal distribution of data, while paired sample t-test was
used to compare the different groups for finding signifi-
cant difference. These results were also analysed using
SPSS version 12.0.1 (Chicago, IL). Differences were con-
sidered statistically significant at p <0.05.Fig. 2 WAVE-3 knockdown and HGF regulated in vitro growth of PC-3 cells. a
5-day period. Growth rate was calculated with a formula: (Absorbance Day3 –
results of three independent experiments performed. Error bars stand for stanResults
Knockdown of WAVE-3 in PC-3 cells and the effect
on cell growth
Cells transfected with the anti-WAVE-3 ribozyme-2 trans-
gene (PC-3 ΔWAVE-3 Rib2) exhibited a markedly reduced
level of WAVE-3 expression compared controls and cells
transfected with the anti-WAVE-3 ribozyme-1 transgene
(PC-3 ΔWAVE-3Rib1) (Fig. 1). There was no change ob-
served in expression of WAVE 1 and 2 following WAVE-3
knock down (data not shown).
WAVE-3 knock down did not demonstrate any effect on
growth of PC-3 cells at 72 h and at 120 h (Fig. 2). There
was marked increased growth with addition of HGF
(40 ng/ml), particularly at 72 h. The growth response be-
tween the different cells was not statistically significant.. The cell growth was measured after 3 days’ culture. b. The growth over
Absorbance Day1)/Absorbance Day1 *100 (%). Shown are representative
dard deviations
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and invasion
Elimination of WAVE-3 did not significantly affect the
cell adhesion with matrix. With the addition of HGF
(40 ng/ml), there was increase in adhesive potential of
cells but there was no statistical difference between the
various cell lines (Data not shown).
WAVE-3 knockdown in PC-3 cells significantly decreased
the invasion of cells through the matrigel basement mem-
brane (Fig. 3). There was significant decrease in the inva-
siveness of PC3WAVE-3KD cells as compared to PC-3WT
and PC-3pEF cells. The addition of HGF 40 μg/ml to the
medium resulted in stimulation to invasive potential of dif-
ferent PC-3 cells to variable degree except the PC-3WAVE-
3KD cells. In addition it was also observed that invaded
cells in PC-3WT and PC-3pEF types were significantly
higher than PC-3WAVE-3KD, even after the addition of
HGF induced stimulation.
Effect of WAVE-3 knock down on cellular motility
We also determined the influence on cell migration using
wounding assay (Fig. 4a and b). Knockdown of WAVE-3
resulted in a decrease of migration in PC-3 cells and led
to a reduced response to HGF stimuli. In line with the
findings of wounding assay, cytodex-2 bead motility assay
showed that elimination of WAVE-3 resulted in reduction
of motile cells (Fig. 4c). HGF promoted the motility of the
control cells but failed to trigger the similar response in
the WAVE-3 knockdown cells.
Effect of WAVE-3 elimination on paxillin and its HGF
induced phosphorylation
To investigate the underlying molecular mechanism, we an-
alyzed the expression of Paxillin, FAK and ERM proteinsFig. 3 Effect of WAVE-3 on the HGF regulated cell invasion. WAVE-3
knockdown impairs the HGF induced invasion of PC-3 cells. The mean
+/−SD number of cells invaded in PC-3WAVE-3KD was 22.10+/−5.13 as
compared to PC-3WT 53.23+/−2.5 and PC-3pEF 48.64+/−7.33 respectively
(p value <0.05). Shown are representative results of three independent
experiments performed. Error bars stand for standard deviationsalong with their phosphorylation status following elim-
ination of WAVE-3 and response to addition of HGF.
No obvious difference was observed for both expression
and distribution of FAK and ERM in the WAVE3 knock-
down cells (Additional file 1: Figure S1, Additional
file 2: Figure S2, Additional file 3: Figure S3, Additional
file 4: Figure S4).
Expression and phosphorylation of these proteins was
detected using immunoprecipitation and subsequent
western blotting. In our experiment, good expression of
paxillin was observed in all cells. There were no changes
in the expression of Paxillin after WAVE-3 knock down.
However the levels of phosphorylated Paxillin were ob-
served to be reduced. When cells were treated with HGF
(40 ng/ml for 30 min), there were increased levels of
phosphorylated Paxillin (Fig. 5b) in PC-3WT and PC-3pEF
cells, but PC-3WAVE-3KD cells failed to show such re-
sponse. Immunofluorescent staining of all three cells
showed prominent fluorescence with Paxillin (Fig. 5a).
With addition of HGF there was enhanced staining of
Paxillin at the focal adhesions of PC-3WT and PC-3pEF
cells. However PC-3WAVE-3KD cell line failed to ex-
hibit such response following addition of HGF.
Knockdown of WAVE-3 influences MMPs activity in PC-3
cells
We screened our three cells for expression of MMP-1,
MMP-2, MMP-7, MMP-9, and MMP-11. There was no
difference in expression of different MMPs except MMP-
2 (Fig. 6a and b). MMP-2 expressed at a relatively low
level in PC-3WAVE-3KD cells. Considering the role of gelati-
nases in prostate cancer invasion, we also analysed the
expression of MMP-2 and MMP-9 in the medium using
western blotting which showed reduced expression of
MMP-2 in the medium collected from PC-3WAVE-3KD
cells. This is consistent with the finding from gelatin
zymography in which MMP-2 activity was significantly
reduced in the medium extracted from PC-3WAVE-3KD
cells compared with the control cells (Fig. 6c).
Discussion
Role of Hepatocyte growth factor/scatter factor (HGF/SF)
is well established in the metastatic process through its ef-
fects on proliferation, dissociation, migration and invasion.
Higher HGF levels have been demonstrated in hormone
refractory prostate cancer and are associated with poor
prognosis. Strong expression of WAVE-3 has been docu-
mented in prostate cancer specimens and invasive cancer
cells from earlier studies in our department [19]. In this
study we focused on role of WAVE-3 in mediation of
these changes with emphasis on prostate cancer cells. Our
present study provides evidence that WAVE-3 has an im-
portant role in HGF induced cellular motility and possible
metastasis without significant effect on cellular growth.
Fig. 4 WAVE-3 and HGF promoted cell migration of prostate cancer cells. a. Migration of PC-3 cells was determined using wounding assay. b. Effect on HGF
promoted migration of prostate cancer cells by WAVE-3 knockdown were assessed using wounding assay. c. WAVE-3 knockdown and HGF regulated cell
migration was also assessed using Cytodex-beads motility assay. Shown are representative results of three independent experiments performed. Error bars stand
for standard deviations
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Fig. 5 Paxillin in the WAVE-3 knockdown PC-3 cells. a. Distribution of Paxillin in the WAVE-3 knockdown cells was examined using immunofluorescent
staining by anti-Paxillin antibody (BD Biosciences, 610051). Arrows point to enhanced staining of Paxillin at the focal adhesions which was not observed in
the WAVE-3 knockdown cells. b. Activation of Paxillin in the PC-3 was determined using immunoprecitation and Western blot. Tyrosine phosphorylated
proteins were immunoprecipitated using PY20 (p-Tyr antibody, Santa Cruz Biotechnology, SC-508). GAPDH was used to probe cell lysates which were the
same input samples for the immunoprecipitation as loading control
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tional studies revealed a statistically significant reduction
in HGF induced cellular motility as compared to controls.
Similar effects were observed in studies involving invasion
through the matrigel basement membrane.
Cell-matrix adhesion is one of the key steps in metas-
tasis and is necessary for invasion through matrix in
order to progress the metastatic process. These adhesion
sites provide important ports for communication of cells
with extracellular matrix and integrins play a pivotal rolein this process. Paxillin is an important molecule in
integrin-mediated adhesion signals and is localized in
dorsal ruffles, at the leading edge of cellular movement
[24]. An increased degree of Paxillin phosphorylation
has been linked to enhanced metastatic potential [25,
26] which indicates its important role in metastasis.
Prior studies have documented enhancement of this
phosphorylation and localization to the focal adhesion
complexes, following addition of HGF in prostate cancer
cells [9]. In our study we found no changes in the
Fig. 6 Knockdown of WAVE-3 reduced MMP-2 activity in the PC-3 cells. a. Expression of MMPs was examined using RT-PCR. b. Semi-quantification was
performed to determine the change of MMP2 transcripts in WAVE-3 knockdown cells compared with PC-3pEF control cells. Integrated density of the
MMP2 bands was normalised against the corresponding GAPDH bands, shown are changes of MMP2 in percentage against its quantity in the control
cells. c. MMP-2 in cell lysate and culture medium was determined using Western blot (top two panels), while the activity of the secreted MMP-2 (culture
medium) was assessed using zymography (bottom panel)
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of WAVE-3. Our results clearly indicate that levels of
HGF induced phosphorylation were significantly reduced
in prostate cancer cells following elimination of WAVE-
3 along with reduced motility and invasion. Theseresults suggest a positive feedback mechanism of
WAVE-3 on Paxillin phosphorylation. This may serve
one of the important mechanisms involved in reduced
cellular response to HGF. Reduction in activated phos-
phorylated Paxillin can result in reduced recruitment of
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promote the hydrolysis of GTP to GDP [6]. These GEFs
and GAPs are directly involved in activation of small
GTPases including Rac and CDC42. Paxillin is phosphory-
lated on multiple tyrosine (PY), serine (PS) and threonine
(PT) residues in response to cell adhesion, and/or expos-
ure to a various soluble growth factors and cytokines [27].
Tyrosine phosphorylation generates docking sites for SH2
domain containing proteins such as Crk (binds PY31, 118)
to facilitate downstream signaling. In contrast, phosphor-
ylation of serine and threonine residues is more likely to
influence paxillin conformation and thereby affect its abil-
ity to interact with specific binding partners.
Numerous studies have shown that the inhibition of
MMPs activity or expression can be a potential target for
the prevention of metastasis [28, 29]. MMP-2 and MMP-9
belong to a gelatinase group of MMPs and their role has
been extensively studied in prostate cancer [30]. Expression
of most MMPs is normally low in tissues, and only induced
when remodelling of the extracellular matrix is required.
MMP expression is primarily regulated at the transcrip-
tional level, although stabilization of MMP transcripts in re-
sponse to growth factors, as well as the influence of
cytokines, also plays a role in the regulation of MMP activ-
ity [31, 32]. The possible involvement of the WAVE pro-
teins in the regulation of MMPs was initially reported by
Suetsugu et al., who showed that down regulation of
WAVE1, but not WAVE2, affected MMP-2 activity [33].
We further investigated the role of MMPs in reduced inva-
sion of prostate cancer cells following WAVE-3 knock
down. Evaluation of expression pattern of different MMPs
revealed relatively low expression of MMP-2 on RT-PCR
after silencing of WAVE-3. Further evaluation with western
blotting and zymography studies showed reduced availabil-
ity of MMP-2 in the medium. This suggests an important
contributory role of MMP-2 in reducing cellular invasion
and movement, after WAVE-3 elimination. It is well
documented that integrins generate adhesion and in-
duce MMP-mediated ECM degradation [34]. Integrin-
mediated adhesion simultaneously activates Rac [35]
and a paxillin-associated kinase, FAK [36]. Both Rac and
FAK enhance secretion and activation of MMP-2
[37-39]. Actin cytoskeleton itself is involved in regula-
tion of MMPs. Treatment of fibroblasts with cytochala-
sins increased expression, secretion, and activation of
MMP-2 [40, 41]. Our prior studies regarding the role of
Paxillin showed markedly reduced levels of phosphory-
lated Paxillin which may indicate towards crosstalk
between these molecules and WAVEs and suggest the
differential effects on the MMP-2 and hence on invasion
as well. Results of our current study clearly suggest the
active role of MMP-2 in reduction of cell motility
and invasion following WAVE-3 elimination. However,
it needs further investigations to study the role ofpathways like ERK1/2 and MAPK/p53, as possible under-
lying mechanism responsible for these changes.
Conclusions
In summary, it is safe to conclude that WAVE-3 plays an
important role during cellular motility and invasion in pros-
tate cancer cells. It is also actively involved in the mediation
of HGF induced changes which possibly promote progres-
sion and invasion. Our results strongly point towards the
active role of phosphorylated Paxillin and MMP-2 as pos-
sible underlying mechanism responsible for these changes.
This study provides a part of larger puzzle underpinning
the process of metastasis which needs to be further investi-
gated for involvement of other pathways.
Additional files
Additional file 1: Figure S1. Immunofluorescent staining (IF) of Ezrin in
PC-3 cells in exposure to HGF (40 ng/ml) using an anti-Ezrin antibody
(Santa Cruz, SC-6409). A TRITC tagged secondary antibody was used for
the IF. Arrows point to staining of Ezrin.
Additional file 2: Figure S2. IF of FAK in PC-3 cells in exposure to HGF
(40 ng/ml) using an anti-FAK antibody (BD Biosciences, 610087). A FITC
tagged secondary antibody was used for the IF. Arrows point to staining
of FAK.
Additional file 3: Figure S3. Radixin in PC-3 cells in exposure to HGF
(40 ng/ml) was stained using an anti-Ezrin antibody (Santa Cruz, SC-6408)
and a FITC tagged secondary antibody. Arrows point to staining of
Radixin.
Additional file 4: Figure S4. IF was performed for Moesin in PC-3 cells
in exposure to HGF (40 ng/ml) using an anti-Ezrin antibody (Santa Cruz,
SC-13122) and a FITC tagged secondary antibody. Arrows point to
staining of Moesin.
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